Jubilant Pharmova Statistics
Total Valuation
NSE:JUBLPHARMA has a market cap or net worth of INR 141.36 billion. The enterprise value is 161.25 billion.
Market Cap | 141.36B |
Enterprise Value | 161.25B |
Important Dates
The next estimated earnings date is Friday, May 16, 2025.
Earnings Date | May 16, 2025 |
Ex-Dividend Date | Aug 2, 2024 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.13% |
Shares Change (QoQ) | -0.30% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 64.51M |
Valuation Ratios
The trailing PE ratio is 22.54.
PE Ratio | 22.54 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 5.92 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 25.71 |
EV / Sales | 2.28 |
EV / EBITDA | 14.84 |
EV / EBIT | 21.23 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.52 |
Debt / EBITDA | 2.92 |
Debt / FCF | n/a |
Interest Coverage | 2.98 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 5.04% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 13.08M |
Profits Per Employee | 1.16M |
Employee Count | 5,399 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +56.78% in the last 52 weeks. The beta is 1.59, so NSE:JUBLPHARMA's price volatility has been higher than the market average.
Beta (5Y) | 1.59 |
52-Week Price Change | +56.78% |
50-Day Moving Average | 935.06 |
200-Day Moving Average | 985.34 |
Relative Strength Index (RSI) | 47.19 |
Average Volume (20 Days) | 226,107 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:JUBLPHARMA had revenue of INR 70.64 billion and earned 6.27 billion in profits. Earnings per share was 39.50.
Revenue | 70.64B |
Gross Profit | 46.35B |
Operating Income | 7.30B |
Pretax Income | 7.21B |
Net Income | 6.27B |
EBITDA | 9.99B |
EBIT | 7.30B |
Earnings Per Share (EPS) | 39.50 |
Balance Sheet
The company has 10.77 billion in cash and 30.80 billion in debt, giving a net cash position of -20.03 billion.
Cash & Cash Equivalents | 10.77B |
Total Debt | 30.80B |
Net Cash | -20.03B |
Net Cash Per Share | n/a |
Equity (Book Value) | 59.27B |
Book Value Per Share | 373.88 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 65.62%, with operating and profit margins of 10.33% and 8.88%.
Gross Margin | 65.62% |
Operating Margin | 10.33% |
Pretax Margin | 10.20% |
Profit Margin | 8.88% |
EBITDA Margin | 14.14% |
EBIT Margin | 10.33% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.56%.
Dividend Per Share | 5.00 |
Dividend Yield | 0.56% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.13% |
Shareholder Yield | 0.69% |
Earnings Yield | 4.44% |
FCF Yield | n/a |
Stock Splits
The last stock split was on March 17, 2006. It was a forward split with a ratio of 5.
Last Split Date | Mar 17, 2006 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |